🟢 Park Ha Biological Technology is trading 6.8% up today alongside a broader biotech-sector rally

Park Ha Biological Technology is trading at $2.65, up 6.8%, alongside a broader biotech-sector rally; no fresh company-specific catalyst has been identified.

• Its press-release page lists October 2 as the latest release; no volume data was provided.
• Biotech IPO activity remains strong: TRexBio and Retension Pharmaceuticals debuted October 9, bringing 2026 biotech IPOs to 29.
• Major indexes are up modestly, though the biotech-sector backdrop is more relevant.